Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
FEBS Letters
|
June 14, 2002
Role of calmodulin in the modulation of the MAPK signalling pathway and the transactivation of epidermal growth factor receptor mediated by PKC
Francesc Tebar, Anna Lladó, Carlos Enrich
Molecular Biology of the Cell
|
September 3, 2004
Protein kinaseCdelta-calmodulin crosstalk regulates epidermal growth factor receptor exit from early endosomes
Anna Lladó, Francesc Tebar, Maria Calvo, et al.
Frontiers in Bioinformatics
|
October 28, 2022
AutoScanJ: A Suite of ImageJ Scripts for Intelligent Microscopy
Sébastien Tosi, Anna Lladó, Lídia Bardia, et al.
Cellular Signalling
|
March 22, 2008
Calmodulin modulates H-Ras mediated Raf-1 activation
Jemina Moretó, Anna Lladó, Maite Vidal-Quadras, et al.
Nano Letters
|
February 2, 2019
Self-Sensing Enzyme-Powered Micromotors Equipped with pH-Responsive DNA Nanoswitches
Tania Patino, Alessandro Porchetta, Anita Jannasch, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 28, 2020
The Combined Use of Gold Nanoparticles and Infrared Radiation Enables Cytosolic Protein Delivery
Josep Garcia, J Marcos Fernández-Pradas, Anna Lladó, et al.
Traffic (Copenhagen, Denmark)
|
September 3, 2011
Rac1 and calmodulin interactions modulate dynamics of ARF6-dependent endocytosis
Maite Vidal-Quadras, Mariona Gelabert-Baldrich, David Soriano-Castell, et al.
Molecular Biology of the Cell
|
October 26, 2007
Protein kinase Cdelta and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactin
Anna Lladó, Paul Timpson, Sandra Vilà de Muga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 2019
Reversible silencing of endogenous receptors in intact brain tissue using 2-photon pharmacology
Silvia Pittolo, Hyojung Lee, Anna Lladó, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer
Luca Gianni, Anna Lladó, Giulia Bianchi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
FEBS Letters
|
June 14, 2002
Role of calmodulin in the modulation of the MAPK signalling pathway and the transactivation of epidermal growth factor receptor mediated by PKC
Francesc Tebar, Anna Lladó, Carlos Enrich
Molecular Biology of the Cell
|
September 3, 2004
Protein kinaseCdelta-calmodulin crosstalk regulates epidermal growth factor receptor exit from early endosomes
Anna Lladó, Francesc Tebar, Maria Calvo, et al.
Frontiers in Bioinformatics
|
October 28, 2022
AutoScanJ: A Suite of ImageJ Scripts for Intelligent Microscopy
Sébastien Tosi, Anna Lladó, Lídia Bardia, et al.
Cellular Signalling
|
March 22, 2008
Calmodulin modulates H-Ras mediated Raf-1 activation
Jemina Moretó, Anna Lladó, Maite Vidal-Quadras, et al.
Nano Letters
|
February 2, 2019
Self-Sensing Enzyme-Powered Micromotors Equipped with pH-Responsive DNA Nanoswitches
Tania Patino, Alessandro Porchetta, Anita Jannasch, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 28, 2020
The Combined Use of Gold Nanoparticles and Infrared Radiation Enables Cytosolic Protein Delivery
Josep Garcia, J Marcos Fernández-Pradas, Anna Lladó, et al.
Traffic (Copenhagen, Denmark)
|
September 3, 2011
Rac1 and calmodulin interactions modulate dynamics of ARF6-dependent endocytosis
Maite Vidal-Quadras, Mariona Gelabert-Baldrich, David Soriano-Castell, et al.
Molecular Biology of the Cell
|
October 26, 2007
Protein kinase Cdelta and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactin
Anna Lladó, Paul Timpson, Sandra Vilà de Muga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 2019
Reversible silencing of endogenous receptors in intact brain tissue using 2-photon pharmacology
Silvia Pittolo, Hyojung Lee, Anna Lladó, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer
Luca Gianni, Anna Lladó, Giulia Bianchi, et al.
Page
of 2